Endovascular treatment for basilar artery occlusion: A systematic review and meta-analysis.

basilar artery occlusion endovascular treatment mechanical thrombectomy posterior circulation stroke

Journal

European journal of neurology
ISSN: 1468-1331
Titre abrégé: Eur J Neurol
Pays: England
ID NLM: 9506311

Informations de publication

Date de publication:
06 2021
Historique:
received: 15 01 2021
accepted: 16 01 2021
pubmed: 23 1 2021
medline: 13 8 2021
entrez: 22 1 2021
Statut: ppublish

Résumé

Independent randomized controlled clinical trials (RCTs) have provided robust evidence for endovascular treatment (EVT) as the standard of care treatment for acute large vessel occlusions in the anterior circulation. We examined available studies specific to posterior cerebral circulation ischemic strokes to see if any conclusions can be drawn regarding EVT options. We performed a systematic literature search to identify studies evaluating the safety and efficacy of EVT versus standard medical treatment for patients with acute basilar artery occlusion (BAO). We extracted data for outcomes of interest and presented associations between the two groups with the use of risk ratios (RRs) or odds ratios (ORs), with corresponding 95% confidence intervals (CIs). We used a random-effects model to pool the effect estimates. We identified five studies (two RCTs, three observational cohorts) including a total of 1098 patients. Patients receiving EVT had a higher risk of symptomatic intracranial hemorrhage (sICH) compared to those receiving non-interventional medical management (RR 5.42, 95% CI 2.74-10.71). Nonsignificant trends towards modified Rankin Scale (mRS) scores 0-2 (RR 1.02, 95% CI 0.74-1.41), mRS scores 0-3 (RR = 0.97, 95% CI 0.64-1.47), overall functional improvement (OR 0.93, 95% CI 0.57-1.51), and all-cause mortality (RR 1.03, 95% CI 0.78-1.35) at 3 months were seen. Although EVT increases the probability of sICH, the available data do not exclude the possibility of improved functional outcomes over standard therapy. As larger studies are challenged by the perceived lack of equipoise in this vulnerable patient population, results of ongoing RCTs are expected to provide substantial input for future meta-analyses.

Sections du résumé

BACKGROUND AND PURPOSE
Independent randomized controlled clinical trials (RCTs) have provided robust evidence for endovascular treatment (EVT) as the standard of care treatment for acute large vessel occlusions in the anterior circulation. We examined available studies specific to posterior cerebral circulation ischemic strokes to see if any conclusions can be drawn regarding EVT options.
METHODS
We performed a systematic literature search to identify studies evaluating the safety and efficacy of EVT versus standard medical treatment for patients with acute basilar artery occlusion (BAO). We extracted data for outcomes of interest and presented associations between the two groups with the use of risk ratios (RRs) or odds ratios (ORs), with corresponding 95% confidence intervals (CIs). We used a random-effects model to pool the effect estimates.
RESULTS
We identified five studies (two RCTs, three observational cohorts) including a total of 1098 patients. Patients receiving EVT had a higher risk of symptomatic intracranial hemorrhage (sICH) compared to those receiving non-interventional medical management (RR 5.42, 95% CI 2.74-10.71). Nonsignificant trends towards modified Rankin Scale (mRS) scores 0-2 (RR 1.02, 95% CI 0.74-1.41), mRS scores 0-3 (RR = 0.97, 95% CI 0.64-1.47), overall functional improvement (OR 0.93, 95% CI 0.57-1.51), and all-cause mortality (RR 1.03, 95% CI 0.78-1.35) at 3 months were seen.
CONCLUSION
Although EVT increases the probability of sICH, the available data do not exclude the possibility of improved functional outcomes over standard therapy. As larger studies are challenged by the perceived lack of equipoise in this vulnerable patient population, results of ongoing RCTs are expected to provide substantial input for future meta-analyses.

Identifiants

pubmed: 33482047
doi: 10.1111/ene.14751
doi:

Types de publication

Journal Article Meta-Analysis Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

2106-2110

Informations de copyright

© 2021 European Academy of Neurology.

Références

Tsivgoulis G, Safouris A, Katsanos AH, et al. Mechanical thrombectomy for emergent large vessel occlusion: a critical appraisal of recent randomized controlled clinical trials. Brain Behav. 2016;6:e00418.
Sommer P, Posekany A, Serles W, et al. Is Functional Outcome Different in Posterior and Anterior Circulation Stroke? Stroke. 2018;49:2728-2732.
Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009;339:b2700.
Guyatt GH, Oxman AD, Vist G, et al. GRADE guidelines: 4. Rating the quality of evidence-study limitations (risk of bias). J Clin Epidemiol. 2011;64:407-415.
Roloff V, Higgins JP, Sutton AJ. Planning future studies based on the conditional power of a meta-analysis. Stat Med. 2013;32:11-24.
Basilar Artery International Cooperation Study (BASICS). https://clinicaltrials.gov/ct2/show/NCT01717755. Last assessed September 20, 2020.
Liu X, Dai Q, Ye R, et al. Endovascular treatment versus standard medical treatment for vertebrobasilar artery occlusion (BEST): an open-label, randomised controlled trial. Lancet Neurol. 2020;19:115-122.
Chen PM, Pirastehfar M, Hailey L, et al. PREMISE: Posterior Circulation Results Comparing Embolectomy to Medical Intervention in Stroke Emergencies. Cureus. 2019;11:e6000.
Schonewille WJ, Wijman CA, Michel P, et al. Treatment and outcomes of acute basilar artery occlusion in the Basilar Artery International Cooperation Study (BASICS): a prospective registry study. Lancet Neurol. 2009;8:724-730.
Seners P, Dargazanli C, Piotin M, et al. Intended Bridging Therapy or Intravenous Thrombolysis Alone in Minor Stroke With Basilar Artery Occlusion. Stroke. 2021;52:699-702. doi: 10.1161/STROKEAHA.120.030992.
Basilar Artery Occlusion Chinese Endovascular Trial. https://clinicaltrials.gov/ct2/show/NCT02737189. Last assessed September 20, 2020.
Goyal N, Tsivgoulis G, Nickele C, et al. Posterior circulation CT angiography collaterals predict outcome of endovascular acute ischemic stroke therapy for basilar artery occlusion. J Neurointerv Surg. 2016;8:783-786.
Kwak HS, Park JS. Mechanical Thrombectomy in Basilar Artery Occlusion: Clinical Outcomes Related to Posterior Circulation Collateral Score. Stroke. 2020;51:2045-2050.
Bao J, Hong Y, Cui C, et al. Efficacy and safety of endovascular treatment for patients with acute intracranial atherosclerosis-related posterior circulation stroke: a systematic review and meta-analysis. Rev Neurosci. 2020;. Sep 15:/j/revneuro.ahead-of-print/revneuro-2020-0025/revneuro-2020-0025.xml [Epub ahead of print].
Gory B, Mazighi M, Blanc R, et al. Mechanical thrombectomy in basilar artery occlusion: influence of reperfusion on clinical outcome and impact of the first-line strategy (ADAPT vs stent retriever). J Neurosurg. 2018;129:1482-1491.
Alawieh AM, Eid M, Anadani M, et al. Thrombectomy Technique Predicts Outcome in Posterior Circulation Stroke-Insights from the STAR Collaboration. Neurosurgery 2020;87:982-991.
Tsivgoulis G, Katsanos AH, Magoufis G, et al. Percutaneous transluminal angioplasty and stenting for symptomatic intracranial arterial stenosis: a systematic review and meta-analysis. Ther Adv Neurol Disord. 2016;9:351-358.

Auteurs

Aristeidis H Katsanos (AH)

Division of Neurology, McMaster University/Population Health Research Institute, Hamilton, ON, Canada.

Apostolos Safouris (A)

Second Department of Neurology, School of Medicine, Attikon University Hospital, National and Kapodistrian University of Athens, Athens, Greece.
Stroke Unit, Metropolitan Hospital, Piraeus, Greece.
Interventional Neuroradiology, Rabin Medical Center, Tel Aviv, Israel.

Stavros Nikolakopoulos (S)

Department of Primary Education, School of Education, University of Ioannina, Ioannina, Greece.
Department of Biostatistics, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands.

Dimitris Mavridis (D)

Department of Primary Education, School of Education, University of Ioannina, Ioannina, Greece.
Faculté de Médecine, Université Paris Descartes, Paris, France.

Nitin Goyal (N)

Department of Neurology, University of Tennessee Health Science Center, Memphis, TN, USA.
Department of Neurosurgery, University of Tennessee/Semmes-Murphey Clinic, Memphis, TN, USA.

Marios N Psychogios (MN)

Department of Neuroradiology, Clinic for Radiology & Nuclear Medicine, University Hospital Basel, Basel, Switzerland.

Georgios Magoufis (G)

Stroke Unit, Metropolitan Hospital, Piraeus, Greece.

Christos Krogias (C)

Department of Neurology, St. Josef-Hospital, Ruhr-University Bochum, Bochum, Germany.

Luciana Catanese (L)

Division of Neurology, McMaster University/Population Health Research Institute, Hamilton, ON, Canada.

Brian Van Adel (B)

Division of Neurology, Neurosurgery, and Diagnostic Imaging, Hamilton General Hospital, McMaster University, Hamilton, ON, Canada.

Guy Raphaeli (G)

Interventional Neuroradiology, Rabin Medical Center, Tel Aviv, Israel.
Department of Neurology, Rabin Medical Center, Tel Aviv, Israel.

Amrou Sarraj (A)

Department of Neurology, University of Texas at Houston, Houston, TX, USA.

Marios Themistocleous (M)

Department of Neurosurgery, Pediatric Hospital of Athens, Athens, Greece.

Evangelia Kararizou (E)

First Department of Neurology, Eginition Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece.

Guillaume Turc (G)

Department of Neurology, GHU Paris et Psychiatrie et Neurosciences, Paris, France.
Université de Paris, Paris, France.
INSERM U1266, Paris, France.
FHU Neurovasc, Paris, France.

Adam Arthur (A)

Department of Neurosurgery, University of Tennessee/Semmes-Murphey Clinic, Memphis, TN, USA.

Andrei V Alexandrov (AV)

Department of Neurology, University of Tennessee Health Science Center, Memphis, TN, USA.

Georgios Tsivgoulis (G)

Second Department of Neurology, School of Medicine, Attikon University Hospital, National and Kapodistrian University of Athens, Athens, Greece.
Department of Neurology, University of Tennessee Health Science Center, Memphis, TN, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH